XOMA
Price:
$30.7
Market Cap:
$359.33M
XOMA Corporation operates as a biotechnology royalty aggregator in Europe, the United States, and the Asia Pacific. The company engages in helping biotech companies for enhancing human health. It acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. The company focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners. It has a portfolio with approximately 70 assets. XOMA Corporation was incorporated in 1981 and is headquartered in Emeryville, California.[Read more]
Industry
Biotechnology
IPO Date
1986-06-06
Stock Exchange
NASDAQ
Ticker
XOMA
According to XOMA Corporation’s latest financial reports and current stock price. The company's current Current Ratio is 8.71. This represents a change of 15.46% compared to the average of 7.55 of the last 4 quarters.
The mean historical Current Ratio of XOMA Corporation over the last ten years is 5.96. The current 8.71 Current Ratio has changed 14.52% with respect to the historical average. Over the past ten years (40 quarters), XOMA's Current Ratio was at its highest in in the September 2022 quarter at 14.70. The Current Ratio was at its lowest in in the December 2016 quarter at 0.84.
Average
5.96
Median
6.96
Minimum
0.84
Maximum
8.98
Discovering the peaks and valleys of XOMA Corporation Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 612.67%
Maximum Annual Current Ratio = 8.98
Minimum Annual Increase = -73.05%
Minimum Annual Current Ratio = 0.84
Year | Current Ratio | Change |
---|---|---|
2023 | 8.68 | -3.35% |
2022 | 8.98 | 20.13% |
2021 | 7.48 | 4.47% |
2020 | 7.16 | 5.94% |
2019 | 6.76 | -19.08% |
2018 | 8.35 | 40.25% |
2017 | 5.95 | 612.67% |
2016 | 0.84 | -73.05% |
2015 | 3.10 | 34.87% |
2014 | 2.30 | -46.37% |
The current Current Ratio of XOMA Corporation (XOMA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
8.38
5-year avg
7.81
10-year avg
5.96
XOMA Corporation’s Current Ratio is less than Werewolf Therapeutics, Inc. (12.13), less than Edgewise Therapeutics, Inc. (30.24), greater than Decibel Therapeutics, Inc. (3.03), less than Celcuity Inc. (14.95), greater than C4 Therapeutics, Inc. (6.31), less than Third Harmonic Bio, Inc. (41.13), greater than Passage Bio, Inc. (7.67), less than Acrivon Therapeutics, Inc. Common Stock (16.16), less than Eliem Therapeutics, Inc. (60.41), greater than TRACON Pharmaceuticals, Inc. (0.66), less than Rezolute, Inc. (13.39), less than Sio Gene Therapies Inc. (21.97), greater than Vincerx Pharma, Inc. (3.43), greater than Stoke Therapeutics, Inc. (6.67), less than Crinetics Pharmaceuticals, Inc. (16.09), less than Dyne Therapeutics, Inc. (26.63), less than Revolution Medicines, Inc. (15.42), less than Design Therapeutics, Inc. (41.42), greater than Tango Therapeutics, Inc. (7.49), less than Talaris Therapeutics, Inc. (18.64), greater than Achilles Therapeutics plc (8.24),
Company | Current Ratio | Market cap |
---|---|---|
12.13 | $100.30M | |
30.24 | $3.24B | |
3.03 | $123.37M | |
14.95 | $573.97M | |
6.31 | $458.83M | |
41.13 | $499.75M | |
7.67 | $37.06M | |
16.16 | $242.20M | |
60.41 | $342.68M | |
0.66 | $136.30K | |
13.39 | $304.81M | |
21.97 | $30.70M | |
3.43 | $10.91M | |
6.67 | $684.42M | |
16.09 | $5.14B | |
26.63 | $2.90B | |
15.42 | $9.39B | |
41.42 | $300.09M | |
7.49 | $552.33M | |
18.64 | $116.44M | |
8.24 | $42.12M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like XOMA Corporation using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like XOMA Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is XOMA Corporation's Current Ratio?
How is the Current Ratio calculated for XOMA Corporation (XOMA)?
What is the highest Current Ratio for XOMA Corporation (XOMA)?
What is the 3-year average Current Ratio for XOMA Corporation (XOMA)?
What is the 5-year average Current Ratio for XOMA Corporation (XOMA)?
How does the current Current Ratio for XOMA Corporation (XOMA) compare to its historical average?